Condom shelf-life testing on first three lots should be allowed by FDA -- HIMA comments.
This article was originally published in The Gray Sheet
Executive Summary
LATEX CONDOM SHELF-LIFE TESTING ON FIRST THREE LOTS SHOULD BE ALLOWED under FDA rules on condom labeling and expiration dating, the Health Industry Manufacturers Association says in Aug. 22 comments to FDA. Commenting on a May 24 FDA proposed rule, HIMA says the reg should allow testing on three "typical" lots rather than three "discrete and random lots" as proposed by FDA. The proposed rule would allow latex condom expiration dating of up to five years based on short-term accelerated aging studies and follow-up real-time testing ("The Gray Sheet" June 3, p. 10).
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.